Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and
kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic …

Reverse left ventricular (LV) remodeling and recovery of LV function are associated with
improved clinical outcomes in patients with heart failure with reduced ejection fraction. A …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Asymptomatic left ventricular dysfunction (ALVD) is present in 3–6% of the general
population, is associated with reduced quality of life and longevity, and is treatable when …

From the 1Mayo Clinic, Jacksonville, Florida, 2Yale University School of Medicine, New
Haven, Connecticut, 3Cleveland Clinic Lerner College of Medicine of Case Western …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

Background The risk of sudden death has changed over time among patients with
symptomatic heart failure and reduced ejection fraction with the sequential introduction of …

This guideline describes the approach and expertise needed for the genetic evaluation of
cardiomyopathy. First published in 2009 by the Heart Failure Society of America (HFSA), the …

Mitral regurgitation (MR) is one of the most prevalent valve disorders and has numerous
aetiologies, including primary (organic) MR, due to underlying degenerative/structural mitral …

Background Right ventricular (RV) pacing may worsen left ventricular cardiomyopathy in
patients with reduced left ventricular ejection fraction (LVEF) and advanced atrioventricular …